<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-pharmaceuticals-13-00464">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>M.Z.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>W.S.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>D.S.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tian</surname>
    <given-names>G.R.</given-names>
   </name>
   <name>
    <surname>Jeong</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>H.Y.</given-names>
   </name>
  </person-group>
  <article-title>Acyl-CoA: Cholesterol acyltransferase inhibitory activities of fatty acid amides isolated from Mylabris phalerate Pallas</article-title>
  <source>Bioorganic Med. Chem. Lett.</source>
  <year>2004</year>
  <volume>14</volume>
  <fpage>4277</fpage>
  <lpage>4280</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2004.05.086</pub-id>
  <?supplied-pmid 15261286?>
  <pub-id pub-id-type="pmid">15261286</pub-id>
 </element-citation>
</ref>
